Drreddys Laboratories | RDY - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
ANI Pharmaceuticals USD 69.69M 7.11M 2026-03
Aurora Cannabis CAD 68.03M 18.68M 2025-12
Bayer EUR 6.59B 496M 2026-03
Canopy Growth CAD 19.96M 1.83M 2025-12
Cipla INR 32.3B 1.95B 2026-03
Corcept Therapeutics USD 33.31M 7.14M 2026-03
Drreddys Laboratories INR 454.04M 854K 2025-12
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Hikma Pharmaceutical USD 715M 104M 2025-12
Lonza CHF 471M 3M 2024-12
Novartis USD 4.32B 134M 2026-03
Pacira USD 14.01M 1.14M 2026-03
Phibro Animal Health USD 129.64M 3.65M 2026-03
Prestige Brands USD 22.79M 20.15M 2026-03
Richter Gedeon HUF 55.64B 11.84B 2025-12
Sun Pharmaceuticals INR 73.34B 6.28B 2026-03
Supernus Pharmaceuticals USD 10.17M 97.63M 2026-03
Teva Pharmaceutical Industries USD 2.6B 65M 2026-03